MTNB · Matinas BioPharma Holdings, Inc.
$0.18
+0.00 (+0.55%)
At close · Sep 4
Going-concern doubt
— flagged Aug 13, 2026
Substantial doubt about the company's ability to continue as a going concern.
“The Company does not believe that the cash and cash equivalents on hand are sufficient to fund planned operations for a period of at least twelve months from the filing date of these financial statements. As a result, substantial doubt exists about the Company's ability to continue as a going concern.”View the 10-Q filed Aug 13, 2026
Market Cap
$2.67M
Shares
14.69M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 8-K | 2026-09-04 | 2026-08-31 | |
| 10-Q | 2026-08-13 | 2026-06-30 | |
| 8-K | 2026-07-24 | 2026-07-23 | |
| 8-K | 2026-07-13 | 2026-07-10 | |
| 8-K | 2026-06-26 | 2026-06-24 | |
| 10-Q | 2026-05-08 | 2026-03-31 | |
| 8-K | 2026-04-03 | 2026-04-02 | |
| 10-K | 2026-03-31 | 2025-12-31 | |
| 8-K | 2026-01-23 | 2026-01-22 | |
| 8-K | 2025-12-12 | — | |
| 8-K | 2025-11-21 | 2025-11-18 | |
| 10-Q | 2025-11-10 | 2025-09-30 | |
| 8-K | 2025-08-18 | 2025-08-15 | |
| 10-Q | 2025-08-14 | 2025-06-30 | |
| 8-K | 2025-08-06 | — | |
| 8-K | 2025-06-23 | — | |
| 10-Q | 2025-05-15 | 2025-03-31 | |
| DEF 14A | 2025-05-12 | — | |
| 8-K | 2025-05-02 | 2025-04-30 | |
| 10-K | 2025-04-15 | 2024-12-31 | |
| 8-K | 2025-04-08 | — | |
| 8-K | 2025-04-04 | — | |
| 8-K | 2025-03-14 | 2025-03-13 | |
| 8-K | 2025-03-11 | — | |
| DEF 14A | 2025-03-03 | — | |
| 8-K | 2025-02-13 | — | |
| 8-K | 2025-02-11 | 2025-02-05 | |
| 8-K | 2025-02-07 | 2025-02-05 | |
| 8-K | 2025-01-24 | 2025-01-21 | |
| 8-K | 2025-01-10 | 2025-01-06 | |
| 8-K | 2024-11-27 | — | |
| 10-Q | 2024-11-13 | 2024-09-30 | |
| 8-K | 2024-10-31 | — | |
| 8-K | 2024-10-24 | 2024-10-23 | |
| 8-K | 2024-09-03 | 2024-08-30 | |
| 8-K | 2024-08-28 | 2024-08-27 | |
| 8-K | 2024-08-20 | — | |
| 8-K | 2024-08-14 | — | |
| 10-Q | 2024-08-14 | 2024-06-30 | |
| 8-K | 2024-05-09 | — | |
| 10-Q | 2024-05-09 | 2024-03-31 | |
| 8-K | 2024-04-05 | 2024-04-02 | |
| 8-K | 2024-03-28 | — | |
| 10-K | 2024-03-27 | 2023-12-31 | |
| 8-K | 2024-03-27 | — | |
| 8-K | 2024-03-25 | — | |
| 8-K | 2024-03-22 | — | |
| 8-K | 2024-03-22 | — | |
| 8-K | 2024-02-26 | — | |
| 8-K | 2024-02-20 | — |
Showing 1–50 of 125 filings
Key facts
CIK
1582554
CUSIP
576810303
13F (30d)
15 filings
15 filers
Visit website
Investor relations